Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors

Journal of Clinical Oncology

Volumn 26, Issue 20, 2008, Pages 3297-3298

  Green, Daniel M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; BEP PROTOCOL; VAC PROTOCOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADVANCED CANCER; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CREATININE CLEARANCE; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG MEGADOSE; GERM CELL TUMOR; HEARING LOSS; HUMAN; KALIURESIS; LOW DRUG DOSE; MAGNESIUM EXCRETION; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NOTE; OTOTOXICITY; PNEUMONIA; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; YOLK SAC TUMOR; ADOLESCENT; ARTICLE; CANCER INVASION; CANCER STAGING; CHILD; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; MALE; MORTALITY; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RISK ASSESSMENT; SURVIVAL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 49149124750     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.5324     Document Type: Note

References (19)

1. Brodeur GM, Howarth CB, Pratt CB, et al: Malignant germ cell tumors in 57 children and adolescents. Cancer 48:1890-1898, 1981
2. Chretien PB, Milam JD, Foote FW, et al: Embryonal adenocarcinomas (a type of malignant teratoma) of the sacrococcygeal region: Clinical and pathological aspects of 21 cases. Cancer 26:522-535, 1970
3. Raney RB Jr, Chatten J, Littman P, et al: Treatment strategies for infants with malignant sacrococcygeal teratoma. J Pediatr Surg 16:573-577, 1981
4. Einhorn LH, Donohue J: Cis-diamminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 87:293-298, 1977
5. Skipper HE: On Reducing Treatment Failures due to Overgrowth of Specifically and Permanently Resistant Cells (Murine Leukemias). Birmingham, AL, Southern Research Institute, 1978
6. Santoro A, Bonadonna G, Bonfante V, et al: Alternating drug combinations in the treatment of advanced Hodgkin's disease. N Engl J Med 306:770-775, 1982
7. Weinstein HJ, Mayer RJ, Rosenthal DS, et al: Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303:473-478, 1980
8. Jacobs EM: Combination chemotherapy of metastatic germinal cell tumors and soft part sarcomas. Cancer 25:324-332, 1970
9. Cangir A, Smith J, van Eys J: Improved prognosis in children with ovarian cancers following modified VAC (vincristine sulfate, dactinomycin and cyclophosphamide) chemotherapy. Cancer 42:1234-1238, 1978
10. Slayton RE, Hreshchyshyn MM, Silverberg SC, et al: Treatment of malignant ovarian germ cell tumors: Response to vincristine, dactinomycin and cyclophosphamide (preliminary report). Cancer 42:390-398, 1978
11. Green DM: Evaluation of single dose vincristine, actinomycin D and cyclophosphamide in childhood solid tumors. Cancer Treat Rep 62:1517-1520, 1978
12. Green DM, Brecher ML, Grossi M, et al: The use of different induction and maintenance chemotherapy regimens for the treatment of advanced yolk sac tumors. J Clin Oncol 1:111-116, 1983
13. Flamant F, Baranzelli MC, Kalifa C, et al: Treatment of malignant germ cell tumors in children: Experience of the Institut Gustave Roussy and the French Society of Pediatric Oncology. Crit Rev Oncol Hematol 10:99-110, 1990
14. Baranzelli MC, Kramar A, Bouffet E, et al: Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 17:1212, 1999
15. Ablin AR, Krailo MD, Ramsay NK, et al: Results of treatment of malignant germ cell tumors in 93 children: A report from the Children's Cancer Study Group. J Clin Oncol 9:1782-1792, 1991
16. Marina N, Fontanesi J, Kun L, et al: Treatment of childhood germ cell tumors: Review of the St. Jude experience from 1979 to 1988. Cancer 70:2568-2575, 1992
17. Mann JR, Raafat F, Robinson K, et al: The United Kingdom Children's Cancer Study Group's second germ cell tumor study: Carboplatinum, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18:3809-3818, 2000
18. Cushing B, Giller R, Cullen JW, et al: Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high risk malignant germ cell tumors: A pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882. J Clin Oncol 22:2691-2700, 2004
19. Horwich A, Sleijfer DT, Fosså SD, et al: Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: A multi-institutional Medical Research Council/European Organization for Research and Treatment of Cancer trial. J Clin Oncol 15:1844-1852, 1997